X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (56) 56
humans (46) 46
cardiac & cardiovascular systems (45) 45
percutaneous coronary intervention (42) 42
cardiovascular (37) 37
female (37) 37
male (37) 37
middle aged (33) 33
internal medicine (31) 31
mortality (30) 30
stents (30) 30
aged (28) 28
transluminal angioplasty (28) 28
cardiac patients (27) 27
risk factors (25) 25
patient outcomes (24) 24
coronary heart disease (23) 23
treatment outcome (21) 21
heart attacks (19) 19
risk (19) 19
diabetes (18) 18
medical colleges (18) 18
acute coronary syndrome (17) 17
acute coronary syndromes (17) 17
analysis (16) 16
cardiovascular disease (16) 16
intervention (16) 16
thrombosis (16) 16
acute myocardial-infarction (15) 15
care and treatment (15) 15
cardiology (14) 14
diabetes mellitus (14) 14
patients (14) 14
prospective studies (14) 14
stent (14) 14
time factors (14) 14
angioplasty (13) 13
clopidogrel (13) 13
follow-up studies (13) 13
myocardial infarction (13) 13
myocardial-infarction (13) 13
coronary artery disease (12) 12
coronary vessels (12) 12
disease (12) 12
cardiovascular diseases (11) 11
drug-eluting stents (11) 11
health risk assessment (11) 11
peripheral vascular disease (11) 11
registries (11) 11
artery-disease (10) 10
implantation (10) 10
platelet aggregation inhibitors - administration & dosage (10) 10
proportional hazards models (10) 10
stroke (10) 10
atherosclerosis (9) 9
bleeding (9) 9
health aspects (9) 9
heart (9) 9
heart attack (9) 9
hematology (9) 9
implants (9) 9
infarction (9) 9
surgical implants (9) 9
ticlopidine - analogs & derivatives (9) 9
abridged index medicus (8) 8
dual antiplatelet therapy (8) 8
ischemia (8) 8
medical research (8) 8
medicine, experimental (8) 8
prognosis (8) 8
risk assessment (8) 8
task-force (8) 8
usage (8) 8
aged, 80 and over (7) 7
anticoagulants (7) 7
aspirin (7) 7
atrial fibrillation (7) 7
clinical outcomes (7) 7
drug therapy, combination (7) 7
outcomes (7) 7
percutaneous coronary intervention - mortality (7) 7
platelet aggregation inhibitors - adverse effects (7) 7
retrospective studies (7) 7
statins (7) 7
women (7) 7
acute coronary syndrome - blood (6) 6
acute coronary syndrome - mortality (6) 6
acute coronary syndrome - therapy (6) 6
anemia (6) 6
antiplatelet therapy (6) 6
cholesterol (6) 6
coronary angiography (6) 6
coronary artery (6) 6
drug-eluting stent (6) 6
heart diseases (6) 6
inflammation (6) 6
kidney diseases (6) 6
percutaneous coronary intervention - methods (6) 6
platelet aggregation inhibitors - therapeutic use (6) 6
angina pectoris (5) 5
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 11/2016, Volume 88, Issue 5, pp. 707 - 708
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 06/2017, Volume 69, Issue 25, pp. 3055 - 3066
Journal Article
Catheterization and Cardiovascular Interventions, ISSN 1522-1946, 11/2016, Volume 88, Issue 5, pp. 707 - 708
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2017, Volume 120, Issue 5, pp. 747 - 752
Abstract Aim of the study was to evaluate whether growth differentiation factor-15 (GDF-15) plasma concentration at the time of percutaneous coronary... 
Cardiovascular | MORTALITY | ISCHEMIC EVENTS | CARDIAC & CARDIOVASCULAR SYSTEMS | METAANALYSIS | MYOCARDIAL-INFARCTION | RISK STRATIFICATION | ATHEROSCLEROSIS | LIPID-LOWERING THERAPY | ATORVASTATIN | PREDICTION | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Male | Biomarkers - blood | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Dose-Response Relationship, Drug | Growth Differentiation Factor 15 - blood | Acute Coronary Syndrome - surgery | Female | Aged | Percutaneous Coronary Intervention | Transluminal angioplasty | Cardiac patients | Physiological aspects | Dosage and administration | Cardiology | Coronary heart disease | Statins | Cardiovascular agents | Myocardial infarction | Intervention | Surgical implants | Heart attacks | Angioplasty | Clinical trials | Lipids | Cardiovascular disease | Angina | Dosage | Confidence intervals | Classification | Implants | Atherosclerosis | Chronic obstructive pulmonary disease | Hypertension | Risk groups | Mortality | Implantation | Regression analysis | Patients | Cholesterol | Lipoproteins | Coronary vessels | Infarction | Diabetes | Acute coronary syndromes | Differentiation | Health risk assessment | Plasmas (physics) | Index Medicus | Abridged Index Medicus
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2017, Volume 119, Issue 8, pp. 1166 - 1172
Journal Article
American Journal of Cardiology, The, ISSN 0002-9149, 2014, Volume 113, Issue 7, pp. 1099 - 1104
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2014, Volume 9, Issue 4, p. e95055
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 11, pp. A159 - A159
Background Current guidelines recommend high intensity lipid lowering (HILL) for treatment of established coronary artery disease (CAD). Patients were... 
Angioplasty | Coronary vessels | Coronary artery | Cardiovascular disease | Lipids | Coronary artery disease | Heart diseases
Journal Article
Journal Article
Coronary Artery Disease, ISSN 0954-6928, 09/2017, Volume 28, Issue 8, pp. 702 - 709
The patient population with the need for oral anticoagulation to reduce stroke risk associated with atrial fibrillation (AF) and dual antiplatelet therapy to... 
coronary artery disease | dual antiplatelet therapy | atrial fibrillation | percutaneous coronary intervention | nonvitamin K antagonist | oral anticoagulation | CARDIAC & CARDIOVASCULAR SYSTEMS | MYOCARDIAL-INFARCTION | BARE-METAL STENTS | PERCUTANEOUS CORONARY | DRUG-ELUTING STENT | RISK-PREDICTION SCORES | ANTITHROMBOTIC THERAPY | TRIPLE THERAPY | CLINICAL-OUTCOMES | Myocardial Infarction - blood | Myocardial Infarction - mortality | Anticoagulants - administration & dosage | Percutaneous Coronary Intervention - mortality | Humans | Coronary Artery Disease - blood | Percutaneous Coronary Intervention - instrumentation | Atrial Fibrillation - mortality | Clinical Decision-Making | Platelet Aggregation Inhibitors - administration & dosage | Coronary Thrombosis - prevention & control | Stroke - mortality | Atrial Fibrillation - diagnosis | Coronary Thrombosis - blood | Stents | Platelet Aggregation Inhibitors - adverse effects | Coronary Thrombosis - mortality | Stroke - prevention & control | Risk Assessment | Administration, Oral | Atrial Fibrillation - drug therapy | Risk Factors | Treatment Outcome | Coronary Artery Disease - mortality | Anticoagulants - adverse effects | Atrial Fibrillation - blood | Coronary Artery Disease - therapy | Blood Coagulation - drug effects | Coronary Artery Disease - diagnosis | Myocardial Infarction - prevention & control | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects | Practice Guidelines as Topic
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 11, pp. A1443 - A1443
Patients were eligible if Combo stent implantation was attempted, and received dual antiplatelet therapy (DAPT) per local guidelines. Compared to non-DM... 
Bioengineering | Surgical implants | Mascots | Diabetes mellitus | Implants | Diabetes | Stents | Clinical outcomes
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 180 - 180
  Gender-related differences in patient characteristics, time delays, reperfusion therapy, as well as short- and long-term all-cause mortality were... 
Cardiovascular | Internal Medicine | Health aspects | Cardiac patients | Mortality | Studies | Gender differences | Health risk assessment
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 1117 - 1117
  Background: Impella and Intra-aortic balloon pump (IABP) are both used to provide hemodynamic support in high risk percutaneous coronary intervention (hPCI). 
Cardiovascular | Internal Medicine | Transluminal angioplasty | Medical colleges | Stents | Mortality
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 11, pp. 1118 - 1118
  Background: Both Impella and Intra-aortic balloon pump (IABP) are used to provide hemodynamic support in high risk patients undergoing complex percutaneous... 
Cardiovascular | Internal Medicine | Transluminal angioplasty
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.